Salmeterol, combined with the root extract derivative magnesium isoglycyrrhizinate (MgIG), eased the signs and symptoms of chronic obstructive…
Articles by Steve Bryson, PhD
Scientists say the discovery of a triggering enzyme in the lung tissue of people with severe chronic obstructive pulmonary…
Note: This story was updated June 6, 2022, to note that the U.S. Food and Drug Administration has assigned an…
Researchers have developed a new genetic tool for predicting the risk of chronic obstructive pulmonary disease (COPD) in individuals…
The National Institutes of Health (NIH) has awarded Albany Medical College, in New York, a $2.8 million, five-year grant to…
The U.S. Food and Drug Administration (FDA) will allow Sanolla’s VoqX to be used in the clinic, the first…
Molecules called stapled peptides blocked the secretion, or release, of mucin proteins from airway cells and lessened mucus buildup in…
ENA Respiratory is developing its first-in-class, broad-spectrum antiviral nasal spray — known as INNA-051 — for populations at risk…
Animal and human studies highlight the potential of nomacopan, an investigational inhaled medicine to alleviate severe exacerbations caused by inflammatory…
A Chinese remedy called Xuanbai Chengqi decoction, or XBCQ, used to treat chronic obstructive pulmonary disease (COPD), modulated immune cells,…